MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson’s Disease (PADOVA): Rationale, Design, and Baseline Data

    T. Nikolcheva, G. Pagano, N. Pross, T. Simuni, K. Marek, R. Postuma, N. Pavese, F. Stocchi, K. Seppi, A. Monnet, N. Shariati, L. Rutten-Jacobs, S. Zanigni, T. Kustermann, K. Taylor, D. Trundell, H. Svoboda, A. Bonni, P. Fontoura, R. Doody (BASEL, Switzerland)

    Objective: The study will evaluate the efficacy and safety of prasinezumab in individuals with early-stage Parkinson's disease (PD) on stable symptomatic therapy. Background: Available treatments…
  • 2023 International Congress

    Effect and Mechanism of Shaoyao Gancao Decoction(SGD) in Treatment of Pain in Parkinson’s Disease Based on Network Pharmacology and Molecular Docking

    Q. Zhao (Shanghai, China)

    Objective: Based on the method of network pharmacology, this paper discusses the potential effects and mechanisms of SGD in the treatment of pain in PD. Background:…
  • 2023 International Congress

    Clinical-based diagnosis and self-reported Parkinson’s disease in a population-based sample in southern Brazil

    G. Pereira, N. Soares, G. Marconi, C. Sangali, I. Pasuch, C. Bertocchi, N. Bruscato, J. Senger, A. Schumacher-Schuh, C. Rieder (Porto Alegre, Brazil)

    Objective: To report the frequency of self-reported PD and the diagnostic evaluation performed by clinical neurologists in a population-based cohort from south Brazil. Background: It…
  • 2023 International Congress

    Transcranical Pulse Stimulation in Parkinson’s rest tremor: a pilot study.

    P. Manganotti, M. Liccari, TMI. Lombardo, M. Michelutti, M. Catalan (Trieste, Italy)

    Objective: The goal of this paper is to explore a possible effect of TPS on the PD rest tremor circuit, stimulating the motor cortex (M1)…
  • 2023 International Congress

    Machine learning reveals candidate genes from Parkinson’s disease associated loci

    E. Yu, R. Lariviere, R. Thomas, L. Liu, K. Senkevich, E. Fon, Z. Gan-Or (Montreal, Canada)

    Objective: To prioritize candidate genes from Parkinson's disease (PD) genome-wide association studies (GWAS) for future functional studies. According to PubMed, most of the field still…
  • 2023 International Congress

    Cognitive assessment of Parkinson’s disease carriers of the novel p.A30G mutation in the SNCA gene

    C. Koros, I. Alefanti, AM. Simitsi, A. Bougea, N. Papagiannakis, R. Antonelou, C. Kartanou, M. Bozi, I. Pachi, S. Varvaresos, A. Zahou, E. Stanitsa, M. Kodounis, M. Maniati, M. Panas, G. Paraskevas, S. Papageorgiou, C. Potagas, G. Karadima, G. Koutsis, L. Stefanis (Athens, Greece)

    Objective: The aim of the present report was to evaluate the cognitive profile of symptomatic Parkinson’s disease (PD) patients in a p.A30G SNCA genetic cohort.…
  • 2023 International Congress

    Comparing neuromelanin intensity estimation techniques for Parkinson’s disease image analysis

    V. Madge, V. Fonov, A. Bailey, A. Dagher, E. Fon, R. Postuma, DL. Collins (Montréal, Canada)

    Objective: The objective of this study is to compare robust neuromelanin (NM) substantia nigra pars compacta (SN) and locus coeruleus (LC) quantification techniques captured in…
  • 2023 International Congress

    Accelerated longitudinal brain atrophy in the ‘diffuse malignant’ Parkinson’s disease subtype

    SM. Fereshtehnejad, R. Moqadam, R. Postuma, M. Dadar, Y. Zeighami (Ottawa, Canada)

    Objective: To investigate differential pattern of brain atrophy between Parkinson’s disease (PD) clinical subtypes using longitudinally acquired brain magnetic resonance imaging (MRIs). Background: Parkinson’s disease…
  • 2023 International Congress

    Verbal Fluency Changes After Unilateral STN Deep Brain Stimulation in Parkinson’s Disease: A Connectomics-Based Approach

    MJ. Kim, I. Zuccaroli, V. Del Bene, S. Brinkerhoff, R. Martin, J. Olson, M. Nelson, C. Gonzalez, V. Kamath, J. Bentley, B. Guthrie, R. Knight, H. Walker, K. Mills (Baltimore, USA)

    Objective: To investigate neural circuitry associated with verbal fluency changes after STN-DBS in Parkinson’s disease. Background: Despite its substantial motor benefits, subtle cognitive changes can…
  • 2023 International Congress

    Adequate hydration with personalized diet improves bowel function and mobility for people with Parkinson’s (PwP’s) on levodopa/carbidopa intestinal gel (LCIG) infusion therapy

    Y. Ben Mordechai, S. Israeli-Korn, O. Cohen, S. Hassin-Baer (Tel Hashomer, Israel)

    Objective: To investigate the effect of the adequate hydration with personalized diet on bowel function, motor function, and global function in PwP’s on LCIG. Background:…
  • « Previous Page
  • 1
  • …
  • 238
  • 239
  • 240
  • 241
  • 242
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley